Daniel McCormick, a well-established global commercial leader and general manager, is influential in sales, marketing, operations, planning, and strategy. With over twenty-five years of experience, he has substantially contributed to the biotechnology, pharmaceutical, diagnostics, and medical device industries. Originating from Wake County, North Carolina, he is recognized for his unparalleled expertise and accomplishments. In his earlier career, he served honorably as a Marine officer, a role that profoundly influenced his leadership style. He is celebrated among his colleagues for his steadfast commitment to prioritizing the well-being of his team, maintaining a strong sense of accountability, and upholding a clear and compelling sense of purpose. His exceptional leadership abilities have garnered him numerous awards and recognition, solidifying his reputation as a source of inspiration and productivity. Beyond his professional pursuits, he is a dedicated husband and father to four children, with personal interests that span basketball, scuba diving, international travel, and cherishing moments with his family. He is making impactful contributions as the principal of Zensights, a biopharmaceutical consulting firm headquartered in Scottsdale, Arizona. Since taking on this role in September 2022, he has fostered vital connections between biopharmaceutical companies and top-tier industry partners, ensuring these collaborations are tailored to specific needs. His leadership is marked by a commitment to innovation, agility, and delivering cost-effective results, ultimately leading to strong, lasting client relationships. He serves as the president of Generis Global Solutions, a specialized management consulting firm based in Raleigh, North Carolina, a position he has held since 2018. In this capacity, he supports growth-oriented companies and organizations within the life sciences industry, guiding them toward establishing highly efficient and impactful operations. His focus at Generis extends to driving incremental client revenues across various global markets and creating innovative commercial and medical affairs models that maximize impact and return on investment.